Pharma Focus Asia

Tonix Pharmaceuticals Plans to Build New R & D Centre


Tonix Pharmaceuticals Holding Corp builds a new R&D centre for developing vaccines and protein-based therapeutics. The new facility will be located in Massachusetts.


The new R&D centre constructed with an area of 40,000 square foot facility will be used as laboratories to provide R&D functions associated with expanding a portfolio of immunology candidates, including vaccines for COVID-19 and biological products for other disorders.

This expansion is made to strengthen the capabilities in process and analytical development. Since US region, seen to be one of the most quickly emerging infectious diseases prone country, needs more domestic onshore capacity to produce vaccines and hence the new R&D facility will support in making vaccines and biologics products suitable for clinical studies by utilising the growing range of vaccine technologies and protein-based therapeutic platforms.

The R&D facility is anticipated to complete its construction and start its operations in 2022.


NameTonix Pharmaceuticals Holding Corp.
TypeNew R & D Center Constrcution
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?